secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001437749-26-012772
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key expects 50% revenue growth to ~$5M and profitability in 1H 2026
-----------------------------------------------------------------------

- 1H'26 revenue expected ~$5M (+50% YoY vs $3.3M); positive net income vs $1.9M loss in 1H'25.
- Q1'26 rev. expected $2.2M (+37% YoY); Q2'26 rev. expected $2.8M (+65% YoY).
- $1.04M expanded software license renewal with foreign retail bank; $1M+ in scanner and POS contracts.
- Cash position at end of 1H'26 expected to remain in line with $2.7M at year-end 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926012772/0001437749-26-012772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926012772/bkyi20260416_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer